Company Filing History:
Years Active: 2012
Title: Yeong Geon Lee: Innovator in Pharmaceutical Composition
Introduction
Yeong Geon Lee is a notable inventor based in Gunpo-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of premature ejaculation. His innovative work has led to the development of a unique compound that addresses this common issue.
Latest Patents
Yeong Geon Lee holds a patent for 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical compositions for the treatment of premature ejaculation. This patent discloses novel derivatives represented by Formula 1, or pharmaceutically acceptable salts thereof. The pharmaceutical composition includes the compound, which has a short half-life and inhibits the ejaculation process by selectively inhibiting serotonin reuptake via a serotonin reuptake transporter present in a presynaptic neuron. Thus, these compounds are useful in the treatment and prevention of premature ejaculation.
Career Highlights
Yeong Geon Lee is associated with Dong-a Pharmaceutical Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise and dedication have positioned him as a valuable asset in his field.
Collaborations
Some of his coworkers include Soo-Jung Choi and Tae-Kyung Kang, who contribute to the collaborative efforts in research and development at Dong-a Pharmaceutical Co., Ltd.
Conclusion
Yeong Geon Lee's contributions to pharmaceutical innovations, particularly in the treatment of premature ejaculation, highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical treatments.